SCHEMBL12413149

SCHEMBL12413149

CCCCC/C=C\CCCCCCCC(=O)OC(C(=O)OCC)C(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.56
PRKCE Q02156 1/20 0.56
PRKCQ Q04759 1/20 0.56
PRKCD Q05655 1/20 0.56
FAAH O00519 3/20 0.55
DGKA P23743 1/20 0.52
LMNA P02545 3/20 0.51
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
ALOX15 P16050 2/20 0.50
HSD17B10 Q99714 2/20 0.50
HPGD P15428 1/20 0.50
CNR1 P21554 1/20 0.50
CNR2 P34972 1/20 0.50
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
SLC6A5 Q9Y345 1/20 0.49
LPAR1 Q92633 1/20 0.48
GMNN O75496 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10087785 1.00 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL10087781 1.00 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL10087782 1.00 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL19359749 1.00 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL12116939 1.00 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL12438061 1.00 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL10087784 0.96 ALDH1A1 (0.57) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL12116936 0.96 ALDH1A1 (0.57) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL18853734 0.96 ALDH1A1 (0.57) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL12414973 0.96 FAAH (0.55) PRKCAPRKCEPRKCQPRKCDFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166194-A1 Asenapine Prodrugs ALKERMES, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166194-A1 Asenapine Prodrugs GRIN1, SCN1B, GRIN2B PRKCA 3981/4885PRKCE 3696/4885PRKCQ 2431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.